Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flos Caryophylli, commonly known as clove, consists of the dried flower buds of *Syzygium aromaticum* (L.) Merr. & L.M. Perry. It is a prominent medicinal herb in Traditional Chinese Medicine (TCM), where it is classified as a 'warming the interior' agent used to treat digestive disorders, nausea, and pain. The primary bioactive constituent is eugenol, which provides significant antioxidant, antimicrobial, and analgesic properties. Research has demonstrated its potential as a neuraminidase inhibitor for anti-influenza therapy and its efficacy in treating chemotherapy-induced nausea and vomiting (CINV), diarrhea, and inflammatory conditions like rheumatoid arthritis when used in combination therapies or traditional formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on flos caryophylli.